Factors associated with delay in treatment initiation for pulmonary tuberculosis

David J. Roberts, Trish Mannes, Neville Q. Verlander, Charlotte Anderson

Source: ERJ Open Res, 6 (1) 00161-2019; 10.1183/23120541.00161-2019
Journal Issue: January
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
David J. Roberts, Trish Mannes, Neville Q. Verlander, Charlotte Anderson. Factors associated with delay in treatment initiation for pulmonary tuberculosis. ERJ Open Res, 6 (1) 00161-2019; 10.1183/23120541.00161-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Factors associated with completion of tuberculosis treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 428s
Year: 2005

The factors associated to pulmonary impairment in patients with treated tuberculosis
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012

Factors influencing on late bacteriological conversion in pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 420s
Year: 2005

Factors associated with thromboembolic events in patients with pulmonary tuberculosis
Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Year: 2020


Risk factors associated with death in pulmonary tuberculosis
Source: Annual Congress 2009 - Socio-economic impact of tuberculosis
Year: 2009


Risk factors for paradoxical response during adequate tuberculosis treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 649s
Year: 2005

Factors effecting the development of radiological sequelae of pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 32s
Year: 2004

Factors associated with sputum culture conversion in patients with pulmonary tuberculosis
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017


Diagnosis and treatment delay in patients with pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 520s
Year: 2003

The assessment of risk factors and treatment of pulmonary TB relapses
Source: Eur Respir J 2006; 28: Suppl. 50, 129s
Year: 2006

Factors relevant to bronchostenosis after treatment of endobronchial tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 690s
Year: 2005

Factors related to response to intermittent treatment of mycobacterium avium complex lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 557s
Year: 2006

Factors associated to pulmonary tuberculosis sequelae: A pilot study
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010


Isoniazid resistance is associated with delayed culture conversion during anti-tuberculosis treatment among patients with pulmonary tuberculosis
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018



Causes of delay in the diagnosis of pulmonary tuberculosis
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011

Treatment outcomes of pulmonary tuberculosis cases in Izmit/Turkey
Source: Eur Respir J 2004; 24: Suppl. 48, 651s
Year: 2004

Cough improves earlier than sputum after treatment initiation in hospitalised patients with pulmonary tuberculosis
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020


Factors influencing time to sputum conversion in smear-positive pulmonary tuberculosis
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010


Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease
Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017
Year: 2018



Characteristics and risk factors for missed pulmonary tuberculosis
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020